Pregled bibliografske jedinice broj: 170107
Evaluation of Bone Mass in Patients with Inflammatory Bowel Disease
Evaluation of Bone Mass in Patients with Inflammatory Bowel Disease // Abstracts of the 29th European Symposium on Calcified Tissue ; u: Calcified Tissue International 70 (2002) (4) 207-346 ; P-93 / Civitelli, Roberto ; Hruska, Keith ; Ralston, Stuart (ur.).
Lyon: Springer, 2002. str. 282-282 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 170107 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Evaluation of Bone Mass in Patients with Inflammatory Bowel Disease
Autori
Sinčić Mijandrušić, Branka ; Crnčević Orlić, Željka ; Štimac, Davor ; Radaković, Branko ; Jurišić Eržen, Dubravka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Abstracts of the 29th European Symposium on Calcified Tissue ; u: Calcified Tissue International 70 (2002) (4) 207-346 ; P-93
/ Civitelli, Roberto ; Hruska, Keith ; Ralston, Stuart - Lyon : Springer, 2002, 282-282
Skup
European Symposium on Calcified Tissue (29 ; 2002)
Mjesto i datum
Zagreb, Hrvatska, 25.05.2002. - 29.05.2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
inflammatory bowel disease; bone mass
Sažetak
A low bone mineral density (BMD) has been reported in patients with inflammatory bowel diseases (IBD). The prevalence of osteoporosis seems to be higher in patients with Crohn's disease (CD) than in those with ulcerative colitis (UC), whereas the prevalence of osteopenia was found to be similar by most studies. Factors associated with bone loss in IBD are the inflammatory activity, corticosteroid use, duration of disease, male sex, low body-mass index, inactivity, hypogonadism, and in CD smoking and surgical reserction. The purpose of the present study was to determine the prevalence of osteopenia and osteoporosis in IBD patients, and to test the influence of clinical variables (age, sex, disease duration, corticosteroid use) on the bone mineral density (BMD). Fifty eight patients with IBD entered the study. BMD was measured by dual-energy x-ray absorptiometry (DEXA). Overall prevalence of osteopenia and osteoporosis was 42% and 30%, respectively. We found no difference between CD and UC patients. There was also no significant difference regarding clinical variables between patients with normal and low BMD. When patients with CD were analized separately, we found statistically significant negative correlation (with correction for age, sex body mass index and corticosteroid use) between BMD and the duration of disease (r=0.58, p=0.002). We conclude that the IBD patients have well defined osteopenia and osteoporosis, the degree of which is not different in CD and UC. Duration of the disease seems to be the only phenomenon related to the low bone mass.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0062025
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Dubravka Jurišić-Eržen
(autor)
Branko Radaković
(autor)
Davor Štimac
(autor)
Željka Crnčević Orlić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE